Zobrazeno 1 - 10
of 431
pro vyhledávání: '"G. G. Kaplan"'
Autor:
E Kuenzig, J Mason, C N Bernstein, T Gomes, D Juurlink, G G Kaplan, J Peña-Sánchez, L E Targownik, S Vigod, J Begum, Z Nugent, E I Benchimol
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 5:35-37
Background Patients with inflammatory bowel disease (IBD) are more likely to use opioids than those without IBD and are more susceptible to the negative consequences of opioid use, including increased risk of death. Aims Examine trends in the use of
Autor:
S Coward, K Martins, S Klarenbach, K Kroeker, C Ma, R Panaccione, L Richer, C Seow, L E Targownik, G G Kaplan
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 5:33-35
Background In August 2016 Cortiment® was approved for use in ulcerative colitis (UC) patients in Canada, but not approved for reimbursement; the Canadian Agency for Drugs and Technology in Health cited no comparable benefit for its use over other ap
Autor:
L N Caplan, N Sharifi, A Markovinovic, M Herauf, J Quan, L Hracs, J W Windsor, S Coward, C Ma, R Panaccione, B Hagel, G G Kaplan
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:38-39
Background The COVID-19 pandemic caused by the SARS-CoV-2 virus is a rapidly evolving public health emergency in which mundane behaviors such as grocery shopping or restaurant dining are considered high-risk for some, such as persons with inflammator
Autor:
E Kuenzig, M Lebenbaum, J Mason, M V Vyas, G G Kaplan, S K Murthy, L E Targownik, E I Benchimol
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:13-14
Background The relapsing and remitting symptoms experienced by people with inflammatory bowel disease (IBD), including abdominal pain and diarrhea, may impact their employability and workplace productivity. Purpose Report the impact of IBD on missed
Autor:
A Markovinovic, M Herauf, J Quan, L Hracs, J W Windsor, N Sharifi, S Coward, L Caplan, J Gorospe, C Ma, R Panaccione, R Ingram, J Kanji, G Tipples, J Holodinsky, C Berstein, D Mahoney, S Bernatsky, E Benchimol, G G Kaplan
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:15-16
Background The rapid development and distribution of SARS-CoV-2 vaccines has raised concerns surrounding vaccine safety in immunocompromised populations, such as those with inflammatory bowel disease (IBD). Purpose We described adverse events (AEs) f
Autor:
S K Murthy, G G Kaplan, S Coward, E Kuenzig, E I Benchimol, A Zubieta, A Otley, A Bitton, C N Bernstein, L Targownik, J Jones, J Begum, M Pugliese, H Singh
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:56-57
NOT PUBLISHED AT AUTHOR’S REQUEST Please acknowledge all funding agencies by checking the applicable boxes below CCC, CIHR Disclosure of Interest S. Murthy: None Declared, G. Kaplan Grant / Research support from: Ferring, Janssen, AbbVie, GlaxoSmit
Autor:
E Kuenzig, H Singh, A Bitton, G G Kaplan, M W Carroll, A R Otley, T A Stukel, S Spruin, A M Griffiths, D R Mack, K Jacobson, G C Nguyen, L E Targownik, W El-Matary, E I Benchimol
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:34-35
Background In Canada, the incidence of inflammatory bowel disease (IBD) is increasing faster among those Purpose To compare healthcare utilization and risk of surgery among children diagnosed with IBD across age groups defined by the Paris Classifica
Autor:
E Kuenzig, R Duchen, T D Walters, D R Mack, A M Griffiths, C N Bernstein, G G Kaplan, A R Otley, W Yu, X Wang, J Guan, S Fung, E I Benchimol
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:26-27
Background The incidence of inflammatory bowel disease (IBD) continues to rise rapidly among Canadian children. The care of children results in higher direct healthcare costs than adults with IBD. It is imperative that we identify individuals who wil
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:33-34
Background Throughout the COVID-19 pandemic, one of the major challenges was conveying expert health information, which was evolving rapidly, to confer population-level advice; this was especially relevant to at risk groups, such as those who are imm
Autor:
E Kuenzig, H Singh, A Bitton, G G Kaplan, M W Carroll, A R Otley, T A Stukel, S Spruin, A M Griffiths, D R Mack, K Jacobson, G C Nguyen, L E Targownik, W El-Matary, S Nasiri, E I Benchimol
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:27-28
Background Marked variation in access to care and health services utilization is a marker of variation in quality of care. With the rising incidence of pediatric inflammatory bowel disease (IBD), we must understand variation in access to and outcomes